Tower Research Capital LLC (TRC) - LEXICON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,454
-81.9%
16,930
-62.0%
0.00%
-66.7%
Q2 2023$102,084
+785161.5%
44,578
+694.5%
0.00%
Q1 2023$13
+8.3%
5,611
-11.3%
0.00%
Q4 2022$12
-100.0%
6,324
-67.4%
0.00%
-100.0%
Q3 2022$46,000
+318.2%
19,389
+214.9%
0.00%
Q2 2022$11,000
-67.6%
6,157
-62.1%
0.00%
Q1 2022$34,000
+13.3%
16,265
+111.8%
0.00%
-100.0%
Q4 2021$30,000
-58.9%
7,681
-48.8%
0.00%
-50.0%
Q3 2021$73,000
+305.6%
15,000
+288.9%
0.00%
Q2 2021$18,000
-50.0%
3,857
-37.0%
0.00%
-100.0%
Q1 2021$36,000
+50.0%
6,124
-13.9%
0.00%0.0%
Q4 2020$24,000
-64.2%
7,113
-84.8%
0.00%0.0%
Q3 2020$67,000
+67.5%
46,707
+136.2%
0.00%
-50.0%
Q2 2020$40,000
+122.2%
19,778
+356.9%
0.00%
+100.0%
Q4 2019$18,000
+1700.0%
4,329
+4554.8%
0.00%
Q2 2019$1,000
-85.7%
93
-92.3%
0.00%
Q1 2019$7,000
-46.2%
1,211
-36.1%
0.00%
-100.0%
Q4 2018$13,000
+85.7%
1,894
+205.0%
0.00%0.0%
Q3 2018$7,000
-92.1%
621
-91.7%
0.00%
-80.0%
Q2 2018$89,000
+2125.0%
7,443
+1437.8%
0.01%
Q1 2018$4,000
+100.0%
484
+153.4%
0.00%
Q4 2017$2,000
-95.1%
191
-94.3%
0.00%
-100.0%
Q3 2017$41,000
+70.8%
3,343
+92.1%
0.00%0.0%
Q4 2016$24,000
+140.0%
1,740
+141.7%
0.00%
+50.0%
Q4 2015$10,000
-90.3%
720
-92.5%
0.00%
-80.0%
Q3 2015$103,000
+5050.0%
9,594
+4446.9%
0.01%
Q2 2015$2,0002110.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders